Therapeutic Options in Heavily Pretreated HIV-1 Patients Based on the Genotypic Resistance Patterns

Journal of the International AIDS Society - Switzerland
doi 10.1186/1758-2652-11-s1-p47
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Genotypic Resistance Assay to Antiretrovirals in HIV-1 Infected Individuals

Juntendo Medical Journal
2004English

Prevalence of HIV-1 Integrase Mutations Related to Resistance to Dolutegravir in Raltegravir Naïve and Pretreated Patients

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Identification of HIV-1 Genotypic Resistance in Patients on First-Line Antiretroviral Therapy Using Polymerase Chain Reaction and Sequencing

Infection International
2013English

Topotecan Monotherapy in Heavily Pretreated Patients With Progressive Advanced Stage Neuroendocrine Carcinomas

Journal of Cancer
Oncology
2014English

Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data From a Western Population

OncoTargets and Therapy
OncologyPharmacology
2020English

Developing a Prediction Model for Benefit From Fulvestrant in Heavily Pretreated Metastatic Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2009English

Hiv Resistance to Antiretroviral Drugs: Mechanisms, Genotypic and Phenotypic Resistance Testing in Clinical Practice

Acta Clinica Belgica
Medicine
2002English

Genotypic Tests for Determining Coreceptor Usage of HIV-1

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
2010English

Comparison of an in Vitro Diagnostic Next-Generation Sequencing Assay With Sanger Sequencing for HIV-1 Genotypic Resistance Testing

Journal of Clinical Microbiology
Microbiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy